Apps are now out plus a bunch of new courses
We now have Apps available in the Google Play Store and the Apple App Store. This allows you to leave off on one device and catch up at the same spot on another.
This month we have the following courses live for you:
HEPATOLOGY II MASTERCLASS - 10.5 hours
From this course you will:
CANCER PATHOLOGY REPORTS SERIES with Jessica Moore - 3 hours
The Pathology Report is a critical document in cancer care. There are over 100 different types of cancer with a broad spectrum of different treatments and outcomes. How do we differentiate between the different types and prescribe the best treatment for each? Chances are, the treatment plan for your patient’s cancer diagnosis started with the results in their pathology report.
This diagnostic report details whether a patient has a malignancy, the cellular changes seen under the microscope, whether or not it is confined or has spread to the small vessels or lymph nodes, the tumour type, grade and size and many other features used to provide a “pathologic diagnosis.”
Pathology reports contain a lot of medical terms, most of which, patient’s do not understand. This can contribute to patient anxiety and disempowerment. Naturopathic and integrative medicine providers can benefit from a deep understanding of the language and features included in the pathology report in order to:
In this lecture you will learn about the most common variables described in a pathology report, both conceptually and within clinical context. Several of the most common cancer types will be discussed and real pathology reports will be examined. Some of the genetic testing and other tests often paired with the basic pathology report will be mentioned. The goal is to leave this lecture series with a deeper understanding of the language and variables used to understand a patient’s unique diagnosis and pathology.
MAST CELL ACTIVATION SYNDROME with Theoharis Theoharides - 1 hour
The increase in allergies, asthma, eczema, rhinitis, and food sensitivities that we are seeing is not readily explainable. Also, there are numerous cases of patients presenting with symptoms consistent with atopic disorders but without a recognisable allergic trigger, or with non-allergic triggers. It appears that this changing picture is due to the rapidly growing population of people presenting with Mast Call Activation Syndrome (MCAS).
Patients with MCAS have normal numbers of mast cells but abnormal function of these cells. They may be degranulating independent of the usual triggers, or releasing excessive amounts of inflammatory compounds. Mast cells are found in connective tissues, skin, intestine lining, cardiovascular system, reproductive system, and neural system. They are relatively small and have a cell life span of only up to 12 weeks. When activated mast cells release various chemicals into the blood stream including histamine, serotonin, heparin, chondroitin sulfate, tryptase, chymase, interleukin-4, and TNF-α.
Those people with Mast Cell Activation Syndrome are highly reactive individuals and the high levels of histamine that they are exposed to results in itchy skin, flushing, nasal congestion, headache, nausea, gastric hypersecretion, and wheezing. Because mast cells are so wide-spread there is a long list of conditions that have mast cell involvement. For example, mast cells can disrupt the blood-brain barrier. When toxins enter the brain, the mast cells can become activated causing localised inflammation to certain areas in the brain and also permitting more toxins to enter the brain.
Dr Theoharis Theoharides is an expert in mast cell pathology and has researched and presented extensively on the topic. He was the first to show that mast cells are critical for inflammation, especially in the brain, and that they are involved in a number of inflammatory conditions that worsen with stress, such as allergies, asthma, eczema, psoriasis, migraines, multiple sclerosis and most recently autism spectrum disorder. In this presentation, Theoharis give us new and deep understanding of mast cells and therefore immune system.
A critical aspect of this presentation is that there is a very long list of conditions that mimic MCAS that are not recognised as being mast cell mediated. Recognising mast cell dysfunction as a potential cause of these conditions makes enormous differences to these patients ability to recover and become well. Theoharis dives deep into these conditions and gives you some good tools and strategies to help these patients.
LONG COVID SYNDROME - 2 hours
Post-Covid Syndrome, also known as Long Covid, is defined as symptoms that persist for more than three weeks after the diagnosis of Covid-19. Estimates suggest that up to a third of all people who contract Covid have some form of Post-Covid Syndrome, while around 80% of those that end up in hospital may be affected.
This month we have the following courses live for you:
HEPATOLOGY II MASTERCLASS - 10.5 hours
From this course you will:
- Gain a deep understanding of functional liver physiology and biochemistry
- Discover how to run a comprehensive hepatology assessment
- Learn how to accurately interpret liver tests and what elevated levels of each of the liver enzymes means
- Develop necessary skills to address the causes of many serious liver diseases
- Understand the liver’s role in many of your patients liver, digestive, psychological, immune and many other presentations
- Know how to identify, assess and to treat the unseen epidemic of fatty liver
- Be able to predict liver-related illness in many of your patients
- Gain new strategies to address constipation, T2D, obesity, toxin exposure, intestinal permeability and many more common conditions and symptoms
- Recognise hepatic contributions in many more of your patients
CANCER PATHOLOGY REPORTS SERIES with Jessica Moore - 3 hours
The Pathology Report is a critical document in cancer care. There are over 100 different types of cancer with a broad spectrum of different treatments and outcomes. How do we differentiate between the different types and prescribe the best treatment for each? Chances are, the treatment plan for your patient’s cancer diagnosis started with the results in their pathology report.
This diagnostic report details whether a patient has a malignancy, the cellular changes seen under the microscope, whether or not it is confined or has spread to the small vessels or lymph nodes, the tumour type, grade and size and many other features used to provide a “pathologic diagnosis.”
Pathology reports contain a lot of medical terms, most of which, patient’s do not understand. This can contribute to patient anxiety and disempowerment. Naturopathic and integrative medicine providers can benefit from a deep understanding of the language and features included in the pathology report in order to:
- Better understand a patient’s unique diagnosis and prognosis
- Improve patient-centered communication by providing facts around the pathology
- Empower patients to understand how their diagnosis is being discussed by their doctors
- Improve communication with other multidisciplinary healthcare providers
- Better inform integrative support and therapeutic strategies
In this lecture you will learn about the most common variables described in a pathology report, both conceptually and within clinical context. Several of the most common cancer types will be discussed and real pathology reports will be examined. Some of the genetic testing and other tests often paired with the basic pathology report will be mentioned. The goal is to leave this lecture series with a deeper understanding of the language and variables used to understand a patient’s unique diagnosis and pathology.
MAST CELL ACTIVATION SYNDROME with Theoharis Theoharides - 1 hour
The increase in allergies, asthma, eczema, rhinitis, and food sensitivities that we are seeing is not readily explainable. Also, there are numerous cases of patients presenting with symptoms consistent with atopic disorders but without a recognisable allergic trigger, or with non-allergic triggers. It appears that this changing picture is due to the rapidly growing population of people presenting with Mast Call Activation Syndrome (MCAS).
Patients with MCAS have normal numbers of mast cells but abnormal function of these cells. They may be degranulating independent of the usual triggers, or releasing excessive amounts of inflammatory compounds. Mast cells are found in connective tissues, skin, intestine lining, cardiovascular system, reproductive system, and neural system. They are relatively small and have a cell life span of only up to 12 weeks. When activated mast cells release various chemicals into the blood stream including histamine, serotonin, heparin, chondroitin sulfate, tryptase, chymase, interleukin-4, and TNF-α.
Those people with Mast Cell Activation Syndrome are highly reactive individuals and the high levels of histamine that they are exposed to results in itchy skin, flushing, nasal congestion, headache, nausea, gastric hypersecretion, and wheezing. Because mast cells are so wide-spread there is a long list of conditions that have mast cell involvement. For example, mast cells can disrupt the blood-brain barrier. When toxins enter the brain, the mast cells can become activated causing localised inflammation to certain areas in the brain and also permitting more toxins to enter the brain.
Dr Theoharis Theoharides is an expert in mast cell pathology and has researched and presented extensively on the topic. He was the first to show that mast cells are critical for inflammation, especially in the brain, and that they are involved in a number of inflammatory conditions that worsen with stress, such as allergies, asthma, eczema, psoriasis, migraines, multiple sclerosis and most recently autism spectrum disorder. In this presentation, Theoharis give us new and deep understanding of mast cells and therefore immune system.
A critical aspect of this presentation is that there is a very long list of conditions that mimic MCAS that are not recognised as being mast cell mediated. Recognising mast cell dysfunction as a potential cause of these conditions makes enormous differences to these patients ability to recover and become well. Theoharis dives deep into these conditions and gives you some good tools and strategies to help these patients.
LONG COVID SYNDROME - 2 hours
Post-Covid Syndrome, also known as Long Covid, is defined as symptoms that persist for more than three weeks after the diagnosis of Covid-19. Estimates suggest that up to a third of all people who contract Covid have some form of Post-Covid Syndrome, while around 80% of those that end up in hospital may be affected.
- Learn how this virus creates a persistent inflammatory response that has a very slow resolution phase
- Understand the impacts the infection has on the immune system and mitochondrial function
- Discover the proposed mechanisms of cellular dysfunction
- Learn why the inflammatory response to the virus fails to shut down appropriately
- Have a new set of techniques that you can use to boost the effectiveness of practically all of the other therapies you are using
- Discover how specific cytokine patterns manifest the symptom profiles seen in Long COVID
- Understand the conditions that predict a poor response to this infection
Practice Development | Help | Students | Presenters | Legals | All Courses | Subscriptions | About | Contact
More coming your way soon! No spam. Promise.
